Key Highlights: The University of Oxford and Oracle have designed the Global Pathogen Analysis System (GPAS) to identify covid-19 variants The GPAS will analyze and compare the annotated genomic sequence data of the SARS-CoV-2 virus The platform has been built using Oxford’s Scalable Pathogen Pipeline Platform, Oracle APEX, and Oracle Cloud Infrastructure  The First Industry […]

Key Highlights: According to a study it is “almost certain” that a SARS-Cov-2 variation would develop, leading to “current vaccination failure.” Several firms that manufacture Covid-19 vaccines are already conducting research to handle new variations. The chance of this occurring is unclear, but such a variation would constitute a substantial danger. Inevitable New Variant According

Apple adds locations of vaccination centers to its map The new Apple Map update is aimed to take a big leap towards the fight against the pandemic. Both Siri and the nearby feature will now be able to show the exact locations of the COVID-19 vaccination centers. This latest feature uses information provided by VaccineFinder,

On 14th March, the AstraZeneca vaccine of COVID-19 was discontinued by the order of Dutch health officials, after reporting “possible side effects” in Denmark and Norway. Although the ban is issued only for two weeks, the health ministry wants to be careful in such crucial times. The Health Ministry also released a statement,  “Based on

Two teams of researchers have claimed that the newly encountered Coronavirus variant that is spreading rapidly in New York carries a mutation that does have the ability to reduce vaccine effectiveness. Researchers from Caltech & Columbia University who have been conducting the research work in mutated Coronavirus have named this new virus as B.1.526. According

Moderna spokesperson Ray Jordan had earlier explained the process of administering the vaccine. It was a regimen of two vaccine doses of 100 micrograms each, to be given four weeks apart. This plan had earned the vaccine its approval from FDA in December. Federal official Slaoui has clarified the US government’s intention to halve the